SLEEP AID

SLEEP AID was reported 300 times

SLEEP AID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DENTOFACIAL FUNCTIONAL DISORDER 1 0.0769
1 OLFACTORY NERVE DISORDER 2 0.0299
2 COPROLALIA 1 0.0175
3 CAROTID ARTERY ATHEROMA 1 0.0094
4 REACTION TO FOOD ADDITIVE 1 0.0074
5 DERMATOPHYTOSIS 2 0.0070
6 POOR DENTAL CONDITION 2 0.0068
7 ACQUIRED OESOPHAGEAL WEB 2 0.0059
8 BREAST HYPERPLASIA 2 0.0057
9 GINGIVAL INFLAMMATION 1 0.0053
10 SMOOTH MUSCLE ANTIBODY POSITIVE 1 0.0053
11 HEARING DISABILITY 2 0.0051
12 DESMOID TUMOUR 1 0.0048
13 TOURETTE'S DISORDER 1 0.0044
14 SCLERAL HAEMORRHAGE 1 0.0043
15 MUSCULOSKELETAL INJURY 1 0.0041
16 CHILD ABUSE 1 0.0039
17 ORTHOSIS USER 1 0.0036
18 FIBROUS HISTIOCYTOMA 1 0.0028
19 DYSPLASTIC NAEVUS 1 0.0028
20 KERATOCONJUNCTIVITIS SICCA 1 0.0027
21 FLOPPY IRIS SYNDROME 1 0.0027
22 IMPAIRED REASONING 1 0.0026
23 VERTEBRAL OSTEOPHYTE 1 0.0023
24 HAEMANGIOMA OF SKIN 1 0.0023
25 CERUMEN IMPACTION 2 0.0022
26 TEMPORAL ARTERITIS 2 0.0022
27 IMMUNOGLOBULINS INCREASED 1 0.0021
28 AIR EMBOLISM 1 0.0021
29 VERBAL ABUSE 1 0.0020
30 AUTONOMIC NEUROPATHY 2 0.0020
31 BRAIN MIDLINE SHIFT 1 0.0019
32 GINGIVAL DISCOLOURATION 1 0.0019
33 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
34 DEMENTIA WITH LEWY BODIES 2 0.0018
35 LIFE EXPECTANCY SHORTENED 1 0.0018
36 AORTIC CALCIFICATION 1 0.0017
37 PALATAL DISORDER 1 0.0017
38 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
39 INTERNAL INJURY 1 0.0015
40 NASAL OPERATION 1 0.0015
41 HAEMATOSPERMIA 1 0.0014
42 DYSHIDROTIC ECZEMA 1 0.0014
43 BREAST FEEDING 1 0.0013
44 OSTEOSCLEROSIS 2 0.0013
45 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
46 MEAN PLATELET VOLUME DECREASED 1 0.0012
47 EXTENSOR PLANTAR RESPONSE 1 0.0011
48 BLOOD UREA ABNORMAL 1 0.0011
49 SOLAR LENTIGO 1 0.0011
50 PANCREATIC CYST 2 0.0010
51 BLADDER CATHETERISATION 1 0.0010
52 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
53 HYPOGONADISM 1 0.0010
54 CLAUSTROPHOBIA 1 0.0009
55 SUPERFICIAL INJURY OF EYE 1 0.0009
56 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
57 ADMINISTRATION SITE PAIN 1 0.0009
58 OPTIC NERVE INJURY 1 0.0009
59 SENSE OF OPPRESSION 1 0.0008
60 COCCIDIOIDOMYCOSIS 1 0.0008
61 LACUNAR INFARCTION 2 0.0008
62 PHARYNGEAL HAEMORRHAGE 1 0.0008
63 ALLERGY TO CHEMICALS 1 0.0008
64 INFREQUENT BOWEL MOVEMENTS 2 0.0008
65 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
66 ACTINIC KERATOSIS 2 0.0008
67 FEELING GUILTY 1 0.0008
68 SEBORRHOEIC KERATOSIS 1 0.0007
69 NEONATAL DISORDER 1 0.0006
70 LOOSE TOOTH 2 0.0006
71 EDUCATIONAL PROBLEM 1 0.0006
72 SPINAL DEFORMITY 1 0.0006
73 WOUND DEHISCENCE 2 0.0006
74 MILIARIA 1 0.0006
75 CAROTID ARTERY STENOSIS 2 0.0006
76 PRODUCT TAMPERING 1 0.0006
77 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
78 SOFT TISSUE INFECTION 1 0.0005
79 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
80 HOMICIDE 1 0.0005
81 OTOTOXICITY 1 0.0005
82 PLASMACYTOMA 1 0.0005
83 GINGIVAL RECESSION 1 0.0005
84 SENSATION OF HEAVINESS 2 0.0005
85 PROSTATOMEGALY 2 0.0005
86 EJACULATION FAILURE 1 0.0005
87 CHANGE OF BOWEL HABIT 1 0.0005
88 MEDICAL DEVICE PAIN 1 0.0005
89 EXPOSED BONE IN JAW 1 0.0005
90 COLONOSCOPY 1 0.0005
91 MIDDLE EAR EFFUSION 1 0.0005
92 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
93 INCORRECT DOSAGE ADMINISTERED 2 0.0004
94 URINARY TRACT INFECTION BACTERIAL 1 0.0004
95 PARKINSON'S DISEASE 1 0.0004
96 HAEMORRHAGE URINARY TRACT 1 0.0004
97 AORTIC ARTERIOSCLEROSIS 1 0.0004
98 JAW DISORDER 2 0.0004
99 SPINAL COMPRESSION FRACTURE 3 0.0004
100 DRUG SCREEN FALSE POSITIVE 1 0.0004
101 LUNG CONSOLIDATION 1 0.0004
102 TOOTH DISCOLOURATION 1 0.0003
103 DECREASED INTEREST 2 0.0003
104 SELF INJURIOUS BEHAVIOUR 1 0.0003
105 FIBROSIS 1 0.0003
106 DIASTOLIC DYSFUNCTION 1 0.0003
107 SCREAMING 2 0.0003
108 SINUS BRADYCARDIA 3 0.0003
109 VULVOVAGINAL DRYNESS 1 0.0003
110 LIVER ABSCESS 1 0.0003
111 PLASMA CELL MYELOMA RECURRENT 1 0.0003
112 SKIN INJURY 1 0.0003
113 BLOOD CREATININE ABNORMAL 1 0.0003
114 HANGOVER 1 0.0003
115 HAEMORRHAGIC DIATHESIS 1 0.0003
116 FAECES SOFT 2 0.0003
117 GASTROINTESTINAL PAIN 3 0.0003
118 PROTEIN TOTAL DECREASED 1 0.0003
119 PARANASAL SINUS DISCOMFORT 1 0.0003
120 FACE INJURY 1 0.0003
121 REHABILITATION THERAPY 1 0.0003
122 SKIN PAPILLOMA 1 0.0002
123 BLEPHARITIS 1 0.0002
124 MUSCLE DISORDER 2 0.0002
125 TRIGGER FINGER 1 0.0002
126 MUSCLE FATIGUE 1 0.0002
127 INTERVERTEBRAL DISC DISORDER 1 0.0002
128 PURULENT DISCHARGE 1 0.0002
129 ANOREXIA 3 0.0002
130 MUSCLE STRAIN 2 0.0002
131 TONGUE DISCOLOURATION 1 0.0002
132 MELANOCYTIC NAEVUS 1 0.0002
133 SPINAL OSTEOARTHRITIS 2 0.0002
134 PHYSICAL DISABILITY 1 0.0002
135 EYE HAEMORRHAGE 3 0.0002
136 VASCULAR DEVICE INFECTION 1 0.0002
137 RESTLESS LEGS SYNDROME 4 0.0002
138 GINGIVAL BLEEDING 3 0.0002
139 EAR DISORDER 1 0.0002
140 MIDDLE INSOMNIA 4 0.0002
141 ARTERIOSCLEROSIS 2 0.0002
142 SPINAL COLUMN STENOSIS 1 0.0002
143 APHAGIA 1 0.0002
144 HORMONE LEVEL ABNORMAL 1 0.0002
145 COELIAC DISEASE 2 0.0002
146 HOSPICE CARE 2 0.0002
147 VEIN DISORDER 1 0.0002
148 DRUG TOLERANCE 1 0.0002
149 EAR DISCOMFORT 2 0.0002
150 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
151 PERIPHERAL VASCULAR DISORDER 1 0.0002
152 STOMACH DISCOMFORT 1 0.0002
153 MALABSORPTION 1 0.0002
154 INJECTION SITE DISCOMFORT 2 0.0002
155 BODY HEIGHT DECREASED 2 0.0002
156 WOUND INFECTION 2 0.0002
157 NONSPECIFIC REACTION 1 0.0002
158 HYPERKERATOSIS 1 0.0002
159 MITRAL VALVE INCOMPETENCE 2 0.0002
160 PERONEAL NERVE PALSY 1 0.0002
161 IMPAIRED DRIVING ABILITY 2 0.0002
162 NEUROLOGICAL SYMPTOM 1 0.0002
163 VISUAL DISTURBANCE 1 0.0002
164 EXERCISE TOLERANCE DECREASED 1 0.0002
165 ORTHOSTATIC HYPOTENSION 3 0.0002
166 PRODUCT LABEL CONFUSION 1 0.0002
167 HYPOVOLAEMIA 1 0.0002
168 URINE ODOUR ABNORMAL 1 0.0002
169 BRADYKINESIA 1 0.0002
170 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
171 INGUINAL HERNIA 1 0.0002
172 MENISCUS INJURY 1 0.0002
173 SCOLIOSIS 1 0.0002
174 SECRETION DISCHARGE 2 0.0002
175 NASAL DRYNESS 1 0.0002
176 PROCTALGIA 1 0.0002
177 APPLICATION SITE VESICLES 1 0.0002
178 NODULE 2 0.0002
179 CHOLELITHIASIS 5 0.0002
180 GASTRITIS 4 0.0002
181 DYSGRAPHIA 1 0.0002
182 TOOTH INFECTION 2 0.0002
183 WALKING AID USER 1 0.0002
184 PRODUCT FORMULATION ISSUE 1 0.0002
185 TERMINAL STATE 1 0.0001
186 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
187 EYE MOVEMENT DISORDER 1 0.0001
188 HYPOMAGNESAEMIA 2 0.0001
189 INTENTIONAL DRUG MISUSE 3 0.0001
190 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
191 HALLUCINATION, VISUAL 3 0.0001
192 JOINT INJURY 3 0.0001
193 POOR QUALITY SLEEP 3 0.0001
194 FAECES DISCOLOURED 3 0.0001
195 TONGUE DISORDER 1 0.0001
196 HYPERTHYROIDISM 2 0.0001
197 MOUTH HAEMORRHAGE 1 0.0001
198 CARDIOMYOPATHY 2 0.0001
199 KETOACIDOSIS 1 0.0001
200 EMOTIONAL DISORDER 4 0.0001
201 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
202 PELVIC FRACTURE 1 0.0001
203 GASTROINTESTINAL INFLAMMATION 1 0.0001
204 AFFECTIVE DISORDER 1 0.0001
205 BLOOD ALBUMIN DECREASED 1 0.0001
206 BLOOD PRESSURE FLUCTUATION 3 0.0001
207 ABASIA 3 0.0001
208 EMBOLISM 1 0.0001
209 EXPIRED PRODUCT ADMINISTERED 4 0.0001
210 LIVE BIRTH 1 0.0001
211 INADEQUATE ANALGESIA 1 0.0001
212 SCAR 2 0.0001
213 PRODUCT CONTAINER ISSUE 1 0.0001
214 BLOOD MAGNESIUM DECREASED 1 0.0001
215 RASH GENERALISED 3 0.0001
216 LUNG INFILTRATION 1 0.0001
217 TOOTHACHE 2 0.0001
218 BRAIN NEOPLASM 1 0.0001
219 DIVERTICULITIS 3 0.0001
220 THINKING ABNORMAL 2 0.0001
221 DEFORMITY 1 0.0001
222 HEPATIC CIRRHOSIS 2 0.0001
223 LACERATION 1 0.0001
224 FOOT FRACTURE 2 0.0001
225 BLOOD URINE PRESENT 2 0.0001
226 FEELING JITTERY 2 0.0001
227 INCREASED APPETITE 2 0.0001
228 ATELECTASIS 1 0.0001
229 HERNIA 2 0.0001
230 DIZZINESS POSTURAL 1 0.0001
231 VITREOUS FLOATERS 1 0.0001
232 FULL BLOOD COUNT DECREASED 2 0.0001
233 MOTOR DYSFUNCTION 1 0.0001
234 SLUGGISHNESS 1 0.0001
235 INITIAL INSOMNIA 1 0.0001
236 THERAPY CESSATION 5 0.0001
237 RIB FRACTURE 2 0.0001
238 INJECTION SITE WARMTH 2 0.0001
239 PULMONARY HYPERTENSION 2 0.0001
240 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
241 RENAL PAIN 1 0.0001
242 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
243 RETCHING 2 0.0001
244 HIP FRACTURE 3 0.0001
245 DECREASED ACTIVITY 1 0.0001
246 PRURITUS GENERALISED 2 0.0001
247 PHARYNGITIS STREPTOCOCCAL 1 0.0001
248 BLOOD GLUCOSE FLUCTUATION 1 0.0001
249 INJECTION SITE NODULE 1 0.0001
250 FOOT DEFORMITY 1 0.0001
251 SKIN DISORDER 3 0.0001
252 GLOSSODYNIA 2 0.0001
253 ORAL PAIN 2 0.0001
254 OCULAR DISCOMFORT 1 0.0001
255 EYE PAIN 5 0.0001
256 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
257 DERMATITIS CONTACT 1 0.0001
258 SCAB 1 0.0001
259 MICTURITION URGENCY 1 0.0001
260 METASTASES TO LUNG 1 0.0001
261 INSOMNIA 23 0.0001
262 ELECTROLYTE IMBALANCE 1 0.0001
263 CAESAREAN SECTION 1 0.0001
264 VASCULITIS 1 0.0001
265 COVID-19 PNEUMONIA 1 0.0001
266 HYPERLIPIDAEMIA 1 0.0001
267 WRIST FRACTURE 1 0.0001
268 HEPATITIS C 1 0.0001
269 NOCTURIA 1 0.0001
270 PRESYNCOPE 2 0.0001
271 LUNG DISORDER 4 0.0001
272 LIVER INJURY 2 0.0001
273 MUSCLE SPASTICITY 1 0.0001
274 CARDIOMEGALY 1 0.0001
275 OSTEONECROSIS OF JAW 2 0.0001
276 TOOTH EXTRACTION 1 0.0001
277 INJECTION SITE DISCOLOURATION 1 0.0001
278 AGGRESSION 4 0.0001
279 INTESTINAL OBSTRUCTION 3 0.0001
280 BRAIN OEDEMA 1 0.0001
281 COLITIS 3 0.0001
282 MYDRIASIS 1 0.0001
283 ERECTILE DYSFUNCTION 2 0.0001
284 INFLAMMATION 4 0.0001
285 HIATUS HERNIA 1 0.0001
286 INJECTION SITE INDURATION 1 0.0001
287 DEEP VEIN THROMBOSIS 5 0.0001
288 IMMUNE SYSTEM DISORDER 1 0.0001
289 ADVERSE REACTION 1 0.0001
290 HAIR TEXTURE ABNORMAL 1 0.0001
291 FEAR 2 0.0001
292 JAUNDICE 2 0.0001
293 PAIN OF SKIN 2 0.0001
294 DISTURBANCE IN ATTENTION 4 0.0001
295 SINUS CONGESTION 1 0.0001
296 INFLUENZA 8 0.0001
297 ROAD TRAFFIC ACCIDENT 3 0.0001
298 MASS 1 0.0001
299 WITHDRAWAL SYNDROME 3 0.0001
300 DEVICE OCCLUSION 1 0.0001
301 SKIN REACTION 1 0.0001
302 BLINDNESS UNILATERAL 1 0.0001
303 HYPOACUSIS 3 0.0001
304 MENTAL DISORDER 3 0.0001
305 NEEDLE ISSUE 2 0.0001
306 BRONCHITIS 5 0.0001
307 PULMONARY MASS 1 0.0001
308 BONE LOSS 1 0.0001
309 DEVICE FAILURE 1 0.0001
310 VERTIGO 4 0.0001
311 GYNAECOMASTIA 2 0.0001
312 LIMB DISCOMFORT 2 0.0001
313 MUSCULOSKELETAL CHEST PAIN 1 0.0001
314 COGNITIVE DISORDER 3 0.0001
315 THERAPY PARTIAL RESPONDER 1 0.0001
316 NERVOUS SYSTEM DISORDER 2 0.0001
317 PARAESTHESIA 10 0.0001
318 SCIATICA 1 0.0001
319 BLOOD GLUCOSE DECREASED 3 0.0001
320 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
321 SENSORY DISTURBANCE 1 0.0001
322 BLOOD POTASSIUM INCREASED 1 0.0001
323 EYE DISORDER 2 0.0001
324 PHOTOSENSITIVITY REACTION 1 0.0001
325 TREMOR 10 0.0001
326 VISUAL ACUITY REDUCED 2 0.0001
327 DRY EYE 3 0.0001
328 VIRAL INFECTION 2 0.0001
329 GAIT INABILITY 2 0.0001
330 HEMIPARESIS 1 0.0001
331 FLUSHING 6 0.0001
332 GASTRIC DISORDER 2 0.0001
333 MUSCULOSKELETAL DISCOMFORT 1 0.0001
334 DEVICE USE ERROR 2 0.0001
335 ABDOMINAL DISTENSION 6 0.0001
336 LOCAL SWELLING 1 0.0001
337 AMENORRHOEA 1 0.0001
338 HEART RATE DECREASED 2 0.0001
339 INJURY 4 0.0001
340 COLD SWEAT 1 0.0001
341 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
342 LYMPHOCYTE COUNT DECREASED 1 0.0001
343 PLATELET COUNT DECREASED 6 0.0001
344 MOBILITY DECREASED 4 0.0001
345 CRYING 2 0.0001
346 CONSTIPATION 12 0.0001
347 PANIC ATTACK 2 0.0001
348 HYPERHIDROSIS 7 0.0001
349 CONJUNCTIVITIS 1 0.0001
350 HEPATIC STEATOSIS 1 0.0001
351 BACTERIAL INFECTION 1 0.0001
352 BLISTER 3 0.0001
353 DIABETES MELLITUS 4 0.0001
354 CONVULSION 3 0.0001
355 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
356 EYE IRRITATION 3 0.0001
357 GLAUCOMA 1 0.0001
358 PRESCRIBED OVERDOSE 1 0.0001
359 BONE PAIN 3 0.0001
360 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
361 CATARACT 3 0.0001
362 BLOOD PRESSURE ABNORMAL 1 0.0001
363 UPPER LIMB FRACTURE 1 0.0001
364 PRESCRIBED UNDERDOSE 1 0.0001
365 PRODUCT ADMINISTRATION ERROR 1 0.0000
366 TASTE DISORDER 1 0.0000
367 BODY TEMPERATURE INCREASED 1 0.0000
368 OSTEOPOROSIS 2 0.0000
369 TOOTH LOSS 1 0.0000
370 MOUTH ULCERATION 1 0.0000
371 SKIN CANCER 1 0.0000
372 RHINORRHOEA 3 0.0000
373 BALANCE DISORDER 4 0.0000
374 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
375 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
376 AMNESIA 3 0.0000
377 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
378 ANXIETY 13 0.0000
379 ASTHENIA 17 0.0000
380 FALL 15 0.0000
381 DEHYDRATION 6 0.0000
382 TOOTH DISORDER 1 0.0000
383 RASH MACULO-PAPULAR 1 0.0000
384 INJECTION SITE PRURITUS 3 0.0000
385 PULMONARY OEDEMA 2 0.0000
386 SNEEZING 1 0.0000
387 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
388 PANCREATITIS ACUTE 1 0.0000
389 HEART RATE IRREGULAR 1 0.0000
390 APPLICATION SITE PRURITUS 1 0.0000
391 MUSCULAR WEAKNESS 5 0.0000
392 MUSCLE SPASMS 8 0.0000
393 NASOPHARYNGITIS 8 0.0000
394 HYPERTENSION 9 0.0000
395 OCULAR HYPERAEMIA 2 0.0000
396 DISEASE RECURRENCE 2 0.0000
397 FEELING ABNORMAL 10 0.0000
398 INJECTION SITE URTICARIA 1 0.0000
399 DYSPEPSIA 4 0.0000
400 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
401 EPISTAXIS 3 0.0000
402 AGEUSIA 1 0.0000
403 HYPOAESTHESIA 6 0.0000
404 HALLUCINATION 3 0.0000
405 UNEVALUABLE EVENT 3 0.0000
406 WEIGHT DECREASED 11 0.0000
407 CARDIOVASCULAR DISORDER 1 0.0000
408 HYPOPHAGIA 1 0.0000
409 LOSS OF CONSCIOUSNESS 5 0.0000
410 UNRESPONSIVE TO STIMULI 1 0.0000
411 SKIN ULCER 1 0.0000
412 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
413 APPLICATION SITE ERYTHEMA 1 0.0000
414 JOINT STIFFNESS 1 0.0000
415 ANHEDONIA 1 0.0000
416 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
417 EAR INFECTION 1 0.0000
418 PAIN IN EXTREMITY 11 0.0000
419 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
420 DRUG EFFECT DECREASED 2 0.0000
421 FREQUENT BOWEL MOVEMENTS 1 0.0000
422 BLOOD BILIRUBIN INCREASED 1 0.0000
423 RASH PRURITIC 2 0.0000
424 DEPENDENCE 2 0.0000
425 VISION BLURRED 5 0.0000
426 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
427 HAEMOPTYSIS 1 0.0000
428 PANCYTOPENIA 2 0.0000
429 HYPONATRAEMIA 2 0.0000
430 TARDIVE DYSKINESIA 1 0.0000
431 ASTHMA 4 0.0000
432 PAIN IN JAW 1 0.0000
433 FLATULENCE 2 0.0000
434 URINARY TRACT INFECTION 6 0.0000
435 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
436 RED BLOOD CELL COUNT DECREASED 1 0.0000
437 FATIGUE 27 0.0000
438 DYSSTASIA 1 0.0000
439 PALPITATIONS 4 0.0000
440 DIARRHOEA 22 0.0000
441 ABDOMINAL PAIN UPPER 7 0.0000
442 ACUTE MYOCARDIAL INFARCTION 1 0.0000
443 LABORATORY TEST ABNORMAL 1 0.0000
444 IRRITABILITY 2 0.0000
445 BLOOD POTASSIUM DECREASED 1 0.0000
446 APHASIA 1 0.0000
447 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
448 CORONARY ARTERY DISEASE 1 0.0000
449 STOMATITIS 2 0.0000
450 ILL-DEFINED DISORDER 2 0.0000
451 PLEURAL EFFUSION 2 0.0000
452 EPILEPSY 1 0.0000
453 FEELING HOT 2 0.0000
454 INJECTION SITE RASH 1 0.0000
455 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
456 CHEST PAIN 6 0.0000
457 INJECTION SITE ERYTHEMA 4 0.0000
458 BONE DENSITY DECREASED 1 0.0000
459 DYSPHAGIA 3 0.0000
460 MIGRAINE 3 0.0000
461 CYSTITIS 1 0.0000
462 INTENTIONAL OVERDOSE 2 0.0000
463 MOVEMENT DISORDER 1 0.0000
464 CONFUSIONAL STATE 5 0.0000
465 SWELLING FACE 2 0.0000
466 PRODUCT DOSE OMISSION 2 0.0000
467 BACK PAIN 7 0.0000
468 DYSPNOEA 17 0.0000
469 URINARY RETENTION 1 0.0000
470 DRY SKIN 4 0.0000
471 NEOPLASM MALIGNANT 2 0.0000
472 URTICARIA 5 0.0000
473 RASH 13 0.0000
474 SOMNOLENCE 6 0.0000
475 TYPE 2 DIABETES MELLITUS 1 0.0000
476 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
477 ANGER 1 0.0000
478 HEPATIC ENZYME INCREASED 2 0.0000
479 SINUSITIS 3 0.0000
480 ERYTHEMA 6 0.0000
481 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
482 MEMORY IMPAIRMENT 4 0.0000
483 INJECTION SITE REACTION 2 0.0000
484 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
485 DRUG INEFFECTIVE 37 0.0000
486 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
487 DRUG EFFECT INCOMPLETE 1 0.0000
488 HYPERGLYCAEMIA 1 0.0000
489 INJECTION SITE MASS 1 0.0000
490 DYSGEUSIA 2 0.0000
491 EYE SWELLING 1 0.0000
492 WEIGHT INCREASED 6 0.0000
493 ANAEMIA 5 0.0000
494 GAIT DISTURBANCE 5 0.0000
495 INJECTION SITE SWELLING 2 0.0000
496 DIZZINESS 13 0.0000
497 PRURITUS 10 0.0000
498 PERIPHERAL SWELLING 4 0.0000
499 PLASMA CELL MYELOMA 1 0.0000
500 ARTHRITIS 2 0.0000
501 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
502 NAUSEA 20 0.0000
503 DISORIENTATION 1 0.0000
504 INJECTION SITE BRUISING 2 0.0000
505 CARDIAC FAILURE CONGESTIVE 2 0.0000
506 JOINT SWELLING 3 0.0000
507 EMOTIONAL DISTRESS 3 0.0000
508 PNEUMONIA 8 0.0000
509 DRY MOUTH 2 0.0000
510 DYSKINESIA 1 0.0000
511 BLINDNESS 1 0.0000
512 LUNG NEOPLASM MALIGNANT 1 0.0000
513 ARTHRALGIA 10 0.0000
514 RHABDOMYOLYSIS 1 0.0000
515 SKIN EXFOLIATION 2 0.0000
516 OSTEOARTHRITIS 1 0.0000
517 MYALGIA 4 0.0000
518 RECTAL HAEMORRHAGE 1 0.0000
519 DEVICE LEAKAGE 1 0.0000
520 CONDITION AGGRAVATED 7 0.0000
521 DEVICE DISLOCATION 1 0.0000
522 INTENTIONAL PRODUCT MISUSE 2 0.0000
523 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
524 MUSCULOSKELETAL STIFFNESS 2 0.0000
525 INJECTION SITE PAIN 7 0.0000
526 HEADACHE 14 0.0000
527 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
528 DEVICE ISSUE 2 0.0000
529 THERAPY NON-RESPONDER 1 0.0000
530 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
531 PRODUCT QUALITY ISSUE 3 0.0000
532 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
533 DEPRESSION 5 0.0000
534 INCORRECT DOSE ADMINISTERED 5 0.0000
535 TINNITUS 1 0.0000
536 SKIN DISCOLOURATION 1 0.0000
537 ADVERSE EVENT 2 0.0000
538 HYPOKALAEMIA 1 0.0000
539 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
540 OROPHARYNGEAL PAIN 2 0.0000
541 DECREASED APPETITE 5 0.0000
542 ABDOMINAL PAIN 5 0.0000
543 BLOOD CHOLESTEROL INCREASED 1 0.0000
544 CARDIAC DISORDER 2 0.0000
545 VOMITING 10 0.0000
546 BLOOD GLUCOSE INCREASED 4 0.0000
547 NEUROPATHY PERIPHERAL 2 0.0000
548 PRODUCTIVE COUGH 1 0.0000
549 MULTIPLE SCLEROSIS 1 0.0000
550 CONTUSION 2 0.0000
551 INFECTION 3 0.0000
552 HYPOGLYCAEMIA 1 0.0000
553 ALOPECIA 4 0.0000
554 HEART RATE INCREASED 2 0.0000
555 CELLULITIS 1 0.0000
556 FLUID RETENTION 1 0.0000
557 NERVOUSNESS 1 0.0000
558 HAEMORRHAGE 2 0.0000
559 SPEECH DISORDER 1 0.0000
560 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
561 OEDEMA 1 0.0000
562 TREATMENT NONCOMPLIANCE 1 0.0000
563 DRUG DOSE OMISSION 3 0.0000
564 HAEMATOCHEZIA 1 0.0000
565 ARTHROPATHY 1 0.0000
566 MEDICATION ERROR 1 0.0000
567 NECK PAIN 1 0.0000
568 OXYGEN SATURATION DECREASED 1 0.0000
569 PRODUCT SUBSTITUTION ISSUE 1 0.0000
570 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
571 DYSPHONIA 1 0.0000
572 CHILLS 2 0.0000
573 SURGERY 1 0.0000
574 WHEEZING 1 0.0000
575 THERAPEUTIC RESPONSE DECREASED 1 0.0000
576 SUICIDE ATTEMPT 1 0.0000
577 DISCOMFORT 1 0.0000
578 VISUAL IMPAIRMENT 2 0.0000
579 PRODUCT USE ISSUE 3 0.0000
580 PSORIASIS 2 0.0000
581 FEBRILE NEUTROPENIA 1 0.0000
582 RENAL FAILURE 2 0.0000
583 BLOOD PRESSURE DECREASED 1 0.0000
584 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
585 COUGH 4 0.0000
586 BURNING SENSATION 1 0.0000
587 SLEEP DISORDER 1 0.0000
588 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
589 THERAPY INTERRUPTED 1 0.0000
590 SKIN BURNING SENSATION 1 0.0000
591 RESPIRATORY FAILURE 1 0.0000
592 UNDERDOSE 1 0.0000
593 HOT FLUSH 1 0.0000
594 ACNE 1 0.0000
595 BLOOD PRESSURE INCREASED 2 0.0000
596 PAIN 8 0.0000
597 HOSPITALISATION 2 0.0000
598 DRUG INTERACTION 2 0.0000
599 CARDIAC FAILURE 1 0.0000
600 DRUG DEPENDENCE 2 0.0000
601 PROSTATE CANCER 1 0.0000
602 INFLUENZA LIKE ILLNESS 1 0.0000
603 DRUG ABUSE 1 0.0000
604 COMPLETED SUICIDE 1 0.0000
605 ABDOMINAL DISCOMFORT 2 0.0000
606 CEREBROVASCULAR ACCIDENT 2 0.0000
607 DEATH 10 0.0000
608 PRODUCT STORAGE ERROR 1 0.0000
609 TACHYCARDIA 1 0.0000
610 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
611 GASTROINTESTINAL DISORDER 1 0.0000
612 ADVERSE DRUG REACTION 1 0.0000
613 HYPERSENSITIVITY 2 0.0000
614 BREAST CANCER 1 0.0000
615 SWELLING 1 0.0000
616 PULMONARY EMBOLISM 1 0.0000
617 ATRIAL FIBRILLATION 1 0.0000
618 SYNCOPE 1 0.0000
619 HAEMOGLOBIN DECREASED 1 0.0000
620 ILLNESS 1 0.0000
621 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
622 OVERDOSE 2 0.0000
623 MALAISE 4 0.0000
624 SEPSIS 1 0.0000
625 RHEUMATOID ARTHRITIS 1 0.0000
626 PYREXIA 3 0.0000
627 SEIZURE 1 0.0000
628 DISEASE PROGRESSION 1 0.0000
629 OEDEMA PERIPHERAL 1 0.0000
630 OFF LABEL USE 7 0.0000
631 PRODUCT DOSE OMISSION ISSUE 2 0.0000
632 ACUTE KIDNEY INJURY 1 0.0000